Ertuğrul Bayram

Cukurova University — Turkey

Medicine · Health Sciences

8h-index266citations111works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(15), Lung Cancer Treatments and Mutations(13), HER2/EGFR in Cancer Research(10), Breast Cancer Treatment Studies(8), Inflammatory Biomarkers in Disease Prognosis(8)

Publications111 total

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
Journal of Clinical Medicine·2026Open Access
Abstract PS5-05-14: Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
Clinical Cancer Research·2026
Abstract PS5-02-08: Impact of Prior T-DM1 Exposure on the Efficacy of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer
Clinical Cancer Research·2026
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
Frontiers in Immunology·2026Open Access
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
Clinical & Translational Oncology·2026
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
Scientific Reports·2025Open Access
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival
Journal of bone oncology·2025Open Access
Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study
Discover Oncology·2025Open Access
HER2 POZITIF METASTATIK MEME KANSERLI HASTALARDA TRASTUZUMAB DERUXTECAN’IN GERÇEK YAŞAM VERILERI: TÜRK ONKOLOJI GRUBU ÇOK MERKEZLI ÇALIŞMASI
Kocaeli Üniversitesi - AVESİS·2025
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
Medicina·2025Open Access
Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first‐line therapy in advanced nonuterine leiomyosarcoma: A multicenter real‐world study
International Journal of Cancer·2025
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study
Scientific Reports·2025Open Access
Clinical Evaluation of Patients Using Antineoplastic Chemotherapeutic Agents with Body Composition Monitor Measurement Before and at 3 Months of Treatment
Journal of Clinical Medicine·2025Open Access
Prognostic Insights into Orbital Metastases: A Comprehensive Analysis of Clinical Features and Survival Outcomes
Diagnostics·2025Open Access
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
International Journal of Cancer·2025
406P Risk of second primary cancer in a ten-year follow-up period among turkish breast cancer survivors: Results from the turkish oncology group cohort
Annals of Oncology·2025
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)
Journal of Clinical Medicine·2025Open Access
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
Clinical Lung Cancer·2025· 2 cited
Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors
Medicina·2025· 2 citedOpen Access
Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study
Annals of Saudi Medicine·2025· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Semra Paydaş(17), Mehmet Alı Nahıt Şendur(15), Seda Kahraman(13), Teoman Şakalar(13), Burcu Gülbağcı(10), Fatih Selçukbırıcık(10), Atike Pınar Erdoğan(10), İlhan Hacıbekiroğlu(10), Merve Keskinkılıç(9), Naziyet Köse Baytemür(9), Nail Paksoy(9), Burçin Çakan Demirel(9), Elif Şahin(9), Serkan Menekşe(9), İbrahim Vedat Bayoğlu(9), Deniz Can Güven(9), Burak Bi̇lgi̇n(9), Eda Eylemer Mocan(8), Mustafa Seyyar(8), Arzu Yaren(8)